These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32698193)

  • 1. The bioavailability and maturing clearance of doxapram in preterm infants.
    Flint RB; Simons SHP; Andriessen P; Liem KD; Degraeuwe PLJ; Reiss IKM; Ter Heine R; Engbers AGJ; Koch BCP; Groot R; Burger DM; Knibbe CAJ; Völler S;
    Pediatr Res; 2021 Apr; 89(5):1268-1277. PubMed ID: 32698193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
    Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
    Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age.
    Engbers AGJ; Völler S; Poets CF; Knibbe CAJ; Reiss IKM; Koch BCP; Flint RB; Simons SHP
    Neonatology; 2021; 118(1):106-113. PubMed ID: 33626528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea.
    Ogawa Y; Irikura M; Kobaru Y; Tomiyasu M; Kochiyama Y; Uriu M; Ishitsuka Y; Kondo Y; Yukawa E; Kamada N; Ohno H; Yamazaki T; Irie T
    Eur J Pediatr; 2015 Apr; 174(4):509-18. PubMed ID: 25248340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.
    Engbers AGJ; Flint RB; Völler S; de Klerk JCA; Reiss IKM; Andriessen P; Liem KD; Degraeuwe PLJ; Croubels S; Millecam J; Allegaert K; Simons SHP; Knibbe CAJ
    Br J Clin Pharmacol; 2020 Oct; 86(10):2028-2039. PubMed ID: 32250464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E; Benard M; Hamon I; Casper C; Haddad FE; Boutroy MJ; Hascoët JM
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
    Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
    Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation.
    Sandra L; Smits A; Allegaert K; Nicolaï J; Annaert P; Bouillon T
    Br J Clin Pharmacol; 2021 Apr; 87(4):2089-2097. PubMed ID: 33085795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
    Beaudry MA; Bradley JM; Gramlich LM; LeGatt D
    Dev Pharmacol Ther; 1988; 11(2):65-72. PubMed ID: 3371147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study.
    Bekker A; Capparelli EV; Mirochnick M; Clarke DF; Cotton MF; Shapiro R; McCarthy K; Moye J; Violari A; Chokephaibulkit K; Abrams E; Penazzato M; Ruel TD; Cressey TR
    J Antimicrob Chemother; 2024 Oct; 79(10):2570-2574. PubMed ID: 39092932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Dosing of Doxapram in Preterm Infants Using Continuous Pharmacodynamic Data and Model-Based Pharmacokinetics: An Illustrative Case Series.
    Poppe JA; van Weteringen W; Sebek LLG; Knibbe CAJ; Reiss IKM; Simons SHP; Flint RB
    Front Pharmacol; 2020; 11():665. PubMed ID: 32477133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly maturing fentanyl clearance in preterm neonates.
    Völler S; Flint RB; Andriessen P; Allegaert K; Zimmermann LJI; Liem KD; Koch BCP; Simons SHP; Knibbe CAJ;
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F598-F603. PubMed ID: 31498775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of Paracetamol Elimination Routes in Preterm Neonates Born Below 32 Weeks of Gestation.
    Wu Y; Völler S; Krekels EHJ; Roofthooft DWE; Simons SHP; Tibboel D; Flint RB; Knibbe CAJ
    Pharm Res; 2023 Sep; 40(9):2155-2166. PubMed ID: 37603141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study.
    Keij FM; Schouwenburg S; Kornelisse RF; Preijers T; Mir F; Degraeuwe P; Stolk LM; van Driel A; Kenter S; van der Sluijs J; Heidema J; den Butter PCP; Reiss IKM; Allegaert K; Tramper-Stranders GA; Koch BCP; Flint RB
    Clin Infect Dis; 2023 Nov; 77(11):1595-1603. PubMed ID: 37757471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxapram Treatment and Diaphragmatic Activity in Preterm Infants.
    de Waal CG; Hutten GJ; Kraaijenga JV; de Jongh FH; van Kaam AH
    Neonatology; 2019; 115(1):85-88. PubMed ID: 30352445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption of doxapram in neonates.
    Bairam A; Akramoff-Gershan L; Beharry K; Laudignon N; Papageorgiou A; Aranda JV
    Am J Perinatol; 1991 Mar; 8(2):110-3. PubMed ID: 2006935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ; Ten Hove CH; Onland W; van Kaam AH
    Neonatology; 2017; 111(2):162-171. PubMed ID: 27760427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation.
    Völler S; Flint RB; Stolk LM; Degraeuwe PLJ; Simons SHP; Pokorna P; Burger DM; de Groot R; Tibboel D; Knibbe CAJ;
    Eur J Pharm Sci; 2017 Nov; 109S():S90-S97. PubMed ID: 28506869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic QT/RR relationship of cardiac conduction in premature infants treated with low-dose doxapram hydrochloride.
    Miyata M; Hata T; Kato N; Takeuchi M; Mizutani H; Kubota M; Yamazaki T
    J Perinat Med; 2007; 35(4):330-3. PubMed ID: 17614751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.